All news

After a $56.3M sale, Twist Bioscience (TWST) officer Leproust proposes another share sale.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Emily M. Leproust, an officer and director at Twist Bioscience (TWST), has proposed selling 4,548 common shares valued at $919,373.72, with an approximate sale date of October 5, 2026. This proposed sale follows a significant prior sale on September 17, 2026, where Leproust sold 356,546 shares for over $56.3 million. The article details the proposed transaction and provides context on previous insider sales and related SEC regulations.

Read original source

TWST company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.